352 related articles for article (PubMed ID: 29602464)
1. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females.
Ng QX; Peters C; Venkatanarayanan N; Goh YY; Ho CYX; Yeo WS
Med Hypotheses; 2018 May; 114():49-54. PubMed ID: 29602464
[TBL] [Abstract][Full Text] [Related]
2. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
Barrons R; Tassone D
Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
[TBL] [Abstract][Full Text] [Related]
3. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
Arch Intern Med; 2012 May; 172(9):704-12. PubMed ID: 22782199
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: a study protocol for a randomised controlled trial.
Daniel M; Szymanik-Grzelak H; Turczyn A; Pańczyk-Tomaszewska M
BMC Urol; 2020 Oct; 20(1):168. PubMed ID: 33097017
[TBL] [Abstract][Full Text] [Related]
5. Recurrent urinary tract infections in women: How promising is the use of probiotics?
Gupta V; Nag D; Garg P
Indian J Med Microbiol; 2017; 35(3):347-354. PubMed ID: 29063878
[TBL] [Abstract][Full Text] [Related]
6. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial.
Lee BB; Toh SL; Ryan S; Simpson JM; Clezy K; Bossa L; Rice SA; Marial O; Weber G; Kaur J; Boswell-Ruys C; Goodall S; Middleton J; Tudehope M; Kotsiou G
BMC Urol; 2016 Apr; 16():18. PubMed ID: 27084704
[TBL] [Abstract][Full Text] [Related]
7. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.
Falagas ME; Betsi GI; Tokas T; Athanasiou S
Drugs; 2006; 66(9):1253-61. PubMed ID: 16827601
[TBL] [Abstract][Full Text] [Related]
8. Understanding the potential of lactobacilli in recurrent UTI prevention.
Vagios S; Hesham H; Mitchell C
Microb Pathog; 2020 Nov; 148():104544. PubMed ID: 33010368
[TBL] [Abstract][Full Text] [Related]
9. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.
Abad CL; Safdar N
J Chemother; 2009 Jun; 21(3):243-52. PubMed ID: 19567343
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Trial.
Gupta V; Mastromarino P; Garg R
Clin Infect Dis; 2024 May; 78(5):1154-1161. PubMed ID: 38084984
[TBL] [Abstract][Full Text] [Related]
11. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial.
Toh SL; Lee BB; Ryan S; Simpson JM; Clezy K; Bossa L; Rice SA; Marial O; Weber GH; Kaur J; Boswell-Ruys CL; Goodall S; Middleton JW; Tuderhope M; Kotsiou G
Spinal Cord; 2019 Jul; 57(7):550-561. PubMed ID: 30814670
[TBL] [Abstract][Full Text] [Related]
12. Probiotics to prevent urinary tract infections: the rationale and evidence.
Reid G; Bruce AW
World J Urol; 2006 Feb; 24(1):28-32. PubMed ID: 16389539
[TBL] [Abstract][Full Text] [Related]
13. Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies.
Geerlings SE; Beerepoot MA; Prins JM
Infect Dis Clin North Am; 2014 Mar; 28(1):135-47. PubMed ID: 24484580
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.
Stapleton AE; Au-Yeung M; Hooton TM; Fredricks DN; Roberts PL; Czaja CA; Yarova-Yarovaya Y; Fiedler T; Cox M; Stamm WE
Clin Infect Dis; 2011 May; 52(10):1212-7. PubMed ID: 21498386
[TBL] [Abstract][Full Text] [Related]
15. [Non-antibiotic prophylaxis for recurrent urinary-tract infections].
Beerepoot MA; ter Riet G; Verbon A; Nys S; de Reijke TM; Geerlings SE
Ned Tijdschr Geneeskd; 2006 Mar; 150(10):541-4. PubMed ID: 16566416
[TBL] [Abstract][Full Text] [Related]
16. Non-antibiotic interventions for prevention of urinary tract infections in children: a systematic review and meta-analysis of randomized controlled trials.
Meena J; Thomas CC; Kumar J; Raut S; Hari P
Eur J Pediatr; 2021 Dec; 180(12):3535-3545. PubMed ID: 34156540
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of lactobacillus strains against uropathogens.
Shim YH; Lee SJ; Lee JW
Pediatr Int; 2016 Oct; 58(10):1009-1013. PubMed ID: 26865336
[TBL] [Abstract][Full Text] [Related]
18. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Agents to Decrease New Episodes of Recurrent Lower Urinary Tract Infections in Postmenopausal Women. A Systematic Review.
Dueñas-Garcia OF; Sullivan G; Hall CD; Flynn MK; OʼDell K
Female Pelvic Med Reconstr Surg; 2016; 22(2):63-9. PubMed ID: 26825411
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli.
Delley M; Bruttin A; Richard M; Affolter M; Rezzonico E; Brück WM
FEMS Microbiol Lett; 2015 Jul; 362(13):fnv096. PubMed ID: 26078118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
